Esmeralda Hemme
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum to immunopeptidomics analysis of human atherosclerosis plaques identifies antigenic drivers of atherosclerosis[Atherosclerosis, (409), October 2025, 120509].
Journal: Atherosclerosis
Published: February 26, 2026
Leukemia inhibitory factor receptor inhibition by EC359 reduces atherosclerotic stenosis grade in Ldlr-/- mice.
Journal: European journal of pharmacology
Published: August 27, 2024
Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe-/- mice.
Journal: Atherosclerosis
Published: March 24, 2024
Bruton's Tyrosine Kinase inhibition by Acalabrutinib does not affect early or advanced atherosclerotic plaque size and morphology in Ldlr-/- mice.
Journal: Vascular pharmacology
Published: February 09, 2023
Mast cells participate in smooth muscle cell reprogramming and atherosclerotic plaque calcification.
Mast cells participate in smooth muscle cell reprogramming and atherosclerotic plaque calcification.
Journal: Vascular pharmacology
Published: January 31, 2023
Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells.
Journal: Nature cardiovascular research
Published: August 05, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026